 |
PDBsum entry 1bf7
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cysteine protease
|
PDB id
|
|
|
|
1bf7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Theoretical model |
 |
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cysteine protease
|
 |
|
Title:
|
 |
Molecular model of the cathepsin b-like cysteine protease from the protozoan parasite leishmania major, theoretical model
|
|
Structure:
|
 |
Cathepsin b-like cysteine protease. Chain: null
|
|
Source:
|
 |
Leishmania major. Strain: lv39 (mrho/su/59/p)
|
|
Authors:
|
 |
P.M.Selzer,X.Chen,V.J.Chan,M.Cheng,G.L.Kenyon,I.D.Kuntz, J.A.Sakanari,F.E.Cohen,J.H.Mckerrow
|
|
Key ref:
|
 |
P.M.Selzer
et al.
(1997).
Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors.
Exp Parasitol,
87,
212-221.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-May-98
|
Release date:
|
12-Aug-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Exp Parasitol
87:212-221
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors.
|
|
P.M.Selzer,
X.Chen,
V.J.Chan,
M.Cheng,
G.L.Kenyon,
I.D.Kuntz,
J.A.Sakanari,
F.E.Cohen,
J.H.McKerrow.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of papain, cruzain, and human liver cathepsin B were used
to build homology-based enzyme models of a cathepsin L-like cysteine protease
(cpL) and a cathepsin B-like cysteine protease (cpB) from the protozoan parasite
Leishmania major. Although structurally a member of the cathepsin B subfamily,
the L. major cpB is not able to cleave synthetic substrates having an arginine
in position P2. This biochemical property correlates with the prediction of a
glycine instead of a glutamic acid at position 205 (papain numbering). The
modeled active sites of the L. major cpB and cpL were used to screen the
Available Chemicals Directory (a database of about 150,000 commercially
available compounds) for potential cysteine protease inhibitors, using DOCK3.5.
Based on both steric and force field considerations, 69 compounds were selected.
Of these, 18 showed IC50's between 50 and 100 microM and 3 had IC50's below 50
microM. A secondary library of compounds, originally derived from a structural
screen against the homologous protease of Plasmodium falciparum (falcipain), and
subsequently expanded by combinatorial chemistry, was also screened. Three
inhibitors were identified which were not only effective against the L. major
protease but also inhibited parasite growth at 5-50 microM.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.O.Pereira,
D.M.Assis,
M.A.Juliano,
R.L.Cunha,
C.L.Barbieri,
L.V.do Sacramento,
M.J.Marques,
and
M.H.Dos Santos
(2011).
Natural Products from Garcinia brasiliensis as Leishmania Protease Inhibitors.
|
| |
J Med Food,
14,
557-562.
|
 |
|
|
|
|
 |
M.Indarte,
Y.Liu,
J.D.Madura,
and
C.K.Surratt
(2010).
Receptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling.
|
| |
ACS Chem Neurosci,
1,
223-233.
|
 |
|
|
|
|
 |
C.R.Caffrey,
A.Rohwer,
F.Oellien,
R.J.Marhöfer,
S.Braschi,
G.Oliveira,
J.H.McKerrow,
and
P.M.Selzer
(2009).
A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni.
|
| |
PLoS ONE,
4,
e4413.
|
 |
|
|
|
|
 |
H.Fan,
J.J.Irwin,
B.M.Webb,
G.Klebe,
B.K.Shoichet,
and
A.Sali
(2009).
Molecular docking screens using comparative models of proteins.
|
| |
J Chem Inf Model,
49,
2512-2527.
|
 |
|
|
|
|
 |
M.Hide,
R.Bras-Gonçalves,
and
A.L.Bañuls
(2007).
Specific cpb copies within the Leishmania donovani complex: evolutionary interpretations and potential clinical implications in humans.
|
| |
Parasitology,
134,
379-389.
|
 |
|
|
|
|
 |
M.A.Juliano,
D.R.Brooks,
P.M.Selzer,
H.L.Pandolfo,
W.A.Judice,
L.Juliano,
M.Meldal,
S.J.Sanderson,
J.C.Mottram,
and
G.H.Coombs
(2004).
Differences in substrate specificities between cysteine protease CPB isoforms of Leishmania mexicana are mediated by a few amino acid changes.
|
| |
Eur J Biochem,
271,
3704-3714.
|
 |
|
|
|
|
 |
R.E.Morgan,
and
N.J.Westwood
(2004).
Screening and synthesis: high throughput technologies applied to parasitology.
|
| |
Parasitology,
128,
S71-S79.
|
 |
|
|
|
|
 |
X.Que,
A.Wunderlich,
K.A.Joiner,
and
S.L.Reed
(2004).
Toxopain-1 is critical for infection in a novel chicken embryo model of congenital toxoplasmosis.
|
| |
Infect Immun,
72,
2915-2921.
|
 |
|
|
|
|
 |
Y.A.Sabnis,
P.V.Desai,
P.J.Rosenthal,
and
M.A.Avery
(2003).
Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies.
|
| |
Protein Sci,
12,
501-509.
|
 |
|
|
|
|
 |
K.A.Werbovetz
(2002).
Promising therapeutic targets for antileishmanial drugs.
|
| |
Expert Opin Ther Targets,
6,
407-422.
|
 |
|
|
|
|
 |
M.Klemba,
and
D.E.Goldberg
(2002).
Biological roles of proteases in parasitic protozoa.
|
| |
Annu Rev Biochem,
71,
275-305.
|
 |
|
|
|
|
 |
C.R.Alves,
S.Côrte-Real,
M.De-Freitas Rosa,
and
S.Giovanni-De-Simone
(2000).
Detection of cysteine-proteinases in Leishmania amazonensis promastigotes using a cross-reactive antiserum.
|
| |
FEMS Microbiol Lett,
186,
263-267.
|
 |
|
|
|
|
 |
R.Furmonaviciene,
H.F.Sewell,
and
F.Shakib
(2000).
Comparative molecular modelling identifies a common putative IgE epitope on cysteine protease allergens of diverse sources.
|
| |
Clin Exp Allergy,
30,
1307-1313.
|
 |
|
|
|
|
 |
X.Que,
and
S.L.Reed
(2000).
Cysteine proteinases and the pathogenesis of amebiasis.
|
| |
Clin Microbiol Rev,
13,
196-206.
|
 |
|
|
|
|
 |
M.P.Barrett,
J.C.Mottram,
and
G.H.Coombs
(1999).
Recent advances in identifying and validating drug targets in trypanosomes and leishmanias.
|
| |
Trends Microbiol,
7,
82-88.
|
 |
|
|
|
|
 |
M.Saura,
C.Zaragoza,
A.McMillan,
R.A.Quick,
C.Hohenadl,
J.M.Lowenstein,
and
C.J.Lowenstein
(1999).
An antiviral mechanism of nitric oxide: inhibition of a viral protease.
|
| |
Immunity,
10,
21-28.
|
 |
|
|
|
|
 |
P.M.Selzer,
S.Pingel,
I.Hsieh,
B.Ugele,
V.J.Chan,
J.C.Engel,
M.Bogyo,
D.G.Russell,
J.A.Sakanari,
and
J.H.McKerrow
(1999).
Cysteine protease inhibitors as chemotherapy: lessons from a parasite target.
|
| |
Proc Natl Acad Sci U S A,
96,
11015-11022.
|
 |
|
|
|
|
 |
J.C.Mottram,
D.R.Brooks,
and
G.H.Coombs
(1998).
Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions.
|
| |
Curr Opin Microbiol,
1,
455-460.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |